Your body may be losing fat while gaining muscle, retaining water, or adjusting glycogen storesall of which affect the scale differently than visible fat loss
According to Lilly, the manufacturer of Zepbound, someone with a commercial drug insurance plan that covers Zepbound may pay as low as $25 for a one- or three-month supply of Zepbound
Kidney stones, insulin resistance, and metabolic syndrome
The change in total fat mass, lean mass, and visceral fat mass, measured by DXA, was 35.7%, 14.4%, and 40.8%, respectively, with CagriSema compared to 27.1%, 09.2%, and 32.4% with semaglutide alone, and 20.6%, 10.3%, and 13.4% with cagrilintide alone [41] (Table 1)
Jean-Gilles and his caring team provide ongoing support and medical monitoring to ensure your therapy is both safe and effective